Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Multiple Myeloma (MAG 2002)
NCT01070862Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by CHU Caen Normandie. Started May 2003; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01070862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070862.